Regine Kollek, PhD, received her doctoral degree in molecular biology from the University of Würzburg (Germany), before she spent two years at the Medical School of the University of California, San Diego (USA). From 1981 through 1984, she was senior researcher at the Heinrich-Pette Institute at the University of Hamburg (Germany). From 1985-1987 she was a member of the scientific staff of the Inquiry Commission on "Chances and Risks of Gene-Technology" of the German parliament in Bonn. After that she joined an interdisciplinary research group at the Hamburger Institute for Social Research, working on sociology of science and technology and risk theory.
Since 1995 she has been professor for biomedical technology assessment at the University of Hamburg and head of a research group dedicated to the study of the implications of modern biotechnology in medicine at the Research Centre for Biotechnology, Society and the Environment. Her research focuses on the ethical and societal implications of modern biotechnology and genetics in medicine. Her latest books are on predictive genetic diagnosis (2008) and on pharmacogenetics and individualised therapy (2004). She is member of the German Ethics Council and of the International Bioethics Committee of UNESCO.